Two secondary leukemias among 15 children given oral etoposide.
Schiavetti
A
A
Department of Pediatrics, University La Sapienza, Viale Regina Elena 324, Rome 00161, Italy.
Varrasso
G
G
Maurizi
P
P
Castello
M A
MA
D002648:Child; D005047:Etoposide / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007948:Leukemia, Monocytic, Acute / Q000139:chemically induced*; D015473:Leukemia, Promyelocytic, Acute / Q000139:chemically induced*; D016609:Neoplasms, Second Primary / Q000139:chemically induced*; D009447:Neuroblastoma / Q000188:drug therapy
D005047:Etoposide